Citadel Advisors’s CytRx Corp CYTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-53,300
| Closed | -$34K | – | 10370 |
|
|
2019
Q1 | $34K | Buy |
53,300
+4,400
| +9% | +$2.77K | ﹤0.01% | 8966 |
|
|
2018
Q4 | $22K | Sell |
48,900
-15,000
| -23% | -$10.4K | ﹤0.01% | 8725 |
|
|
2018
Q3 | $67K | Buy |
63,900
+30,500
| +91% | +$34.4K | ﹤0.01% | 8732 |
|
|
2018
Q2 | $38K | Buy |
33,400
+8,200
| +33% | +$12.3K | ﹤0.01% | 8499 |
|
|
2018
Q1 | $40K | Buy |
25,200
+14,900
| +145% | +$26.2K | ﹤0.01% | 7990 |
|
|
2017
Q4 | $17K | Buy |
10,300
+6,917
| +204% | +$14.3K | ﹤0.01% | 7860 |
|
|
2017
Q3 | $8K | Sell |
3,383
-2,367
| -41% | -$8K | ﹤0.01% | 7448 |
|
|
2017
Q2 | $22K | Buy |
5,750
+283
| +5% | +$967 | ﹤0.01% | 7273 |
|
|
2017
Q1 | $15K | Buy |
5,467
+1,900
| +53% | +$4.81K | ﹤0.01% | 7322 |
|
|
2016
Q4 | $8K | Sell |
3,567
-800
| -18% | -$2.35K | ﹤0.01% | 7160 |
|
|
2016
Q3 | $15K | Sell |
4,367
-966
| -18% | -$4.43K | ﹤0.01% | 7117 |
|
|
2016
Q2 | $71K | Buy |
5,333
+1,883
| +55% | +$31.3K | ﹤0.01% | 6321 |
|
|
2016
Q1 | $55K | Buy |
3,450
+3,000
| +667% | +$41K | ﹤0.01% | 6229 |
|
|
2015
Q4 | $7K | Buy |
+450
| New | +$7.72K | ﹤0.01% | 8395 |
|
|
2015
Q3 | – | Sell |
-3,450
| Closed | -$77K | – | 9688 |
|
|
2015
Q2 | $77K | Buy |
3,450
+2,233
| +183% | +$55.9K | ﹤0.01% | 7342 |
|
|
2015
Q1 | $25K | Sell |
1,217
-83
| -6% | -$1.54K | ﹤0.01% | 7787 |
|
|
2014
Q4 | $21K | Sell |
1,300
-2,167
| -63% | -$33.8K | ﹤0.01% | 7783 |
|
|
2014
Q3 | $53K | Buy |
+3,467
| New | +$68.5K | ﹤0.01% | 6877 |
|
|
2014
Q1 | – | Sell |
-2,833
| Closed | -$107K | – | 8326 |
|
|
2013
Q4 | $107K | Buy |
+2,833
| New | +$51.6K | ﹤0.01% | 5554 |
|
Other funds holding CYTR
Citadel Advisors's CYTR Position: Q1 2019 in Review
Citadel Advisors sold out of CytRx Corp (CYTR) in Q1 2019, closing a stake of 34,569 shares — an estimated $21.7K sold.
Citadel Advisors first reported a position in CYTR in Q2 2013 and held it in 13 quarters. The position peaked at $225K in Q4 2015. 35 funds tracked by Wall St. Rank hold CYTR as of Q1 2019.
- Citadel Advisors reported no remaining CytRx Corp position as of Q1 2019 after selling out during the quarter.
- Citadel Advisors sold 34,569 CytRx Corp shares in Q1 2019, an estimated $21.7K.
- Citadel Advisors first reported a position in CytRx Corp in Q2 2013 and held it in 13 quarters.
- Citadel Advisors's CytRx Corp position peaked at $225K in Q4 2015.
- 35 funds tracked by Wall St. Rank held CytRx Corp as of Q1 2019.
Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.